| scholarly article | Q13442814 |
| P50 | author | Barton Haynes | Q4865631 |
| Myron S. Cohen | Q16733099 | ||
| Bette Korber | Q30505218 | ||
| Yalu Chen | Q91741304 | ||
| Katharine J Bar | Q102210398 | ||
| Chuanxi Sun | Q114512852 | ||
| Elena E Giorgi | Q122828494 | ||
| Peter T. Hraber | Q37366689 | ||
| Charity Morgan | Q50643864 | ||
| Gerald H Learn | Q54541884 | ||
| Beatrice H. Hahn | Q55293537 | ||
| Tanmoy Bhattacharya | Q55414889 | ||
| Alan S. Perelson | Q55719625 | ||
| Jesus F Salazar-Gonzalez | Q57415418 | ||
| Brandon Keele | Q68690678 | ||
| George M. Shaw | Q78514357 | ||
| Joseph J Eron | Q87874621 | ||
| P2093 | author name string | Hui Li | |
| Martin Markowitz | |||
| Joseph E Schumacher | |||
| Shuyi Wang | |||
| Julie M Decker | |||
| Charles B Hicks | |||
| Maria G Salazar | |||
| P2860 | cites work | HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC | Q21559422 |
| Genotypic and phenotypic characterization of HIV-1 patients with primary infection | Q22242245 | ||
| Transmission, acute HIV-1 infection and the quest for strategies to prevent infection | Q22251056 | ||
| Gender differences in HIV-1 diversity at time of infection | Q24706473 | ||
| DnaSP, DNA polymorphism analyses by the coalescent and other methods | Q27860965 | ||
| Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies | Q28307869 | ||
| The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression | Q28507706 | ||
| Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 | ||
| Statistical properties of the number of recombination events in the history of a sample of DNA sequences | Q29617408 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus | Q30350983 | ||
| Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus | Q30376865 | ||
| Modeling sequence evolution in acute HIV-1 infection | Q37384535 | ||
| Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1 | Q37568289 | ||
| Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. | Q39551934 | ||
| Measuring the public-health impact of candidate HIV vaccines as part of the licensing process | Q40121515 | ||
| Recombination: Multiply infected spleen cells in HIV patients | Q43923409 | ||
| GARD: a genetic algorithm for recombination detection | Q45134816 | ||
| Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. | Q45729198 | ||
| Modeling plasma virus concentration during primary HIV infection | Q45743854 | ||
| Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants | Q45867857 | ||
| HIV-1 genomic RNA diversification following sexual and parenteral virus transmission | Q45873185 | ||
| Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission | Q47878972 | ||
| Recco: recombination analysis using cost optimization | Q48024454 | ||
| Detection of acute infections during HIV testing in North Carolina. | Q51974681 | ||
| Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. | Q51993308 | ||
| Reduction of HIV concentration during acute infection: independence from a specific immune response. | Q52312556 | ||
| Incidence of HIV‐1 Dual Infection and Its Association with Increased Viral Load Set Point in a Cohort of HIV‐1 Subtype C–Infected Female Sex Workers | Q57478288 | ||
| HIV vaccine trial results--an opening for further research | Q84754053 | ||
| Virology. Moving forward in HIV vaccine development | Q84989881 | ||
| Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1 | Q33402461 | ||
| Development of topical microbicides to prevent the sexual transmission of HIV | Q33625073 | ||
| Wide variation in the multiplicity of HIV-1 infection among injection drug users | Q33877419 | ||
| Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities | Q34202259 | ||
| Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection | Q34228730 | ||
| Virus population homogenization following acute human immunodeficiency virus type 1 infection | Q34360562 | ||
| Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes | Q34439417 | ||
| Pervasive genomic recombination of HIV-1 in vivo | Q34645720 | ||
| A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo | Q34858885 | ||
| Glycerol monolaurate prevents mucosal SIV transmission | Q34957016 | ||
| Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection | Q35635026 | ||
| The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection | Q35682491 | ||
| Inhibiting sexual transmission of HIV-1 infection | Q35709090 | ||
| Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. | Q35830147 | ||
| Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. | Q35852888 | ||
| HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study | Q36165696 | ||
| Perils at mucosal front lines for HIV and SIV and their hosts | Q36274922 | ||
| Viral dynamics of acute HIV-1 infection | Q36375339 | ||
| Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? | Q36422860 | ||
| Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing | Q36540055 | ||
| Setting the stage: host invasion by HIV. | Q36983857 | ||
| Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. | Q37110723 | ||
| Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants | Q37145228 | ||
| Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. | Q37273086 | ||
| Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | Q37273158 | ||
| The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection | Q37273195 | ||
| Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques | Q37275022 | ||
| Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition | Q37295563 | ||
| Dynamics of HIV-1 recombination in its natural target cells | Q37356815 | ||
| Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection | Q37366149 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 5 | |
| P921 | main subject | men who have sex with men | Q853451 |
| P304 | page(s) | e1000890 | |
| P577 | publication date | 2010-05-13 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. | |
| P478 | volume | 6 |
| Q33869034 | A Bayesian approach to analyse genetic variation within RNA viral populations. |
| Q36207177 | A Generalized Entropy Measure of Within-Host Viral Diversity for Identifying Recent HIV-1 Infections |
| Q33812743 | A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation |
| Q40170253 | A novel preventive strategy against HIV-1 infection: combinatorial use of inhibitors targeting the nucleocapsid and fusion proteins |
| Q38615326 | A strong case for viral genetic factors in HIV virulence |
| Q35729054 | Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection. |
| Q34185814 | Acute HIV-1 Infection |
| Q30781299 | An evaluation of phylogenetic methods for reconstructing transmitted HIV variants using longitudinal clonal HIV sequence data |
| Q28554904 | Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061) |
| Q36110367 | Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana |
| Q37017688 | Animal models for microbicide studies |
| Q37547245 | Antigenic properties of the HIV envelope on virions in solution |
| Q35069151 | Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus. |
| Q47146547 | Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission? |
| Q34058732 | Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies |
| Q33886570 | Association of HIV diversity and survival in HIV-infected Ugandan infants. |
| Q35140968 | Barriers to mucosal transmission of immunodeficiency viruses |
| Q28082862 | Bottlenecks in HIV-1 transmission: insights from the study of founder viruses |
| Q36154165 | CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck |
| Q28657772 | Cellular superspreaders: an epidemiological perspective on HIV infection inside the body |
| Q34620235 | Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users |
| Q40393973 | Characterization of founder viruses in very early SIV rectal transmission |
| Q39398170 | Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection |
| Q64880210 | Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM. |
| Q27691426 | Clinical significance of HIV-1 coreceptor usage |
| Q91656913 | Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-infection Estimation towards Enhanced Vaccine Efficacy Assessment |
| Q36760147 | Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies |
| Q36978861 | Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design |
| Q35219829 | Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection |
| Q39108779 | Complex immune correlates of protection in HIV-1 vaccine efficacy trials |
| Q35788320 | Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China |
| Q92136034 | Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure |
| Q35488153 | Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission |
| Q36205668 | Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages |
| Q98204285 | Defective HIV-1 envelope gene promotes the evolution of the infectious strain through recombination in vitro |
| Q64290549 | Defining early SIV replication and dissemination dynamics following vaginal transmission |
| Q35140263 | Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes |
| Q37252894 | Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection |
| Q35868993 | Designing a genome-based HIV incidence assay with high sensitivity and specificity |
| Q35140450 | Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants. |
| Q34270853 | Detection of retroviral super-infection from non-invasive samples |
| Q95371858 | Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction |
| Q36736392 | Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques |
| Q28551914 | Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus |
| Q35915659 | Differential innate immune responses to low or high dose oral SIV challenge in Rhesus macaques |
| Q37696935 | Disentangling the impact of within-host evolution and transmission dynamics on the tempo of HIV-1 evolution |
| Q40040133 | Donor-Recipient Identification in Para- and Poly-phyletic Trees Under Alternative HIV-1 Transmission Hypotheses Using Approximate Bayesian Computation. |
| Q36105672 | Dose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies |
| Q36000736 | Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape |
| Q33442370 | Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee |
| Q28482493 | Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing |
| Q57484166 | Estimating the mutational fitness effects distribution during early HIV infection |
| Q41926717 | Estimating time of HIV-1 infection from next-generation sequence diversity |
| Q37660267 | Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. |
| Q27468827 | Evidence for Within-Host Genetic Recombination among the Human Pegiviral Strains in HIV Infected Subjects |
| Q56797307 | Evolution of HIV-1 within untreated individuals and at the population scale in Uganda |
| Q35665770 | For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection |
| Q35748138 | Generation and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides |
| Q35826158 | Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages |
| Q39015505 | Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China |
| Q34290999 | Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys |
| Q28271559 | Global epidemiology of HIV infection in men who have sex with men |
| Q37546766 | HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm |
| Q47548221 | HIV evolution and diversity in ART-treated patients |
| Q40478109 | HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy. |
| Q37853935 | HIV sexual transmission and microbicides |
| Q36526615 | HIV transmission |
| Q37851950 | HIV vaccines: progress to date. |
| Q36997294 | HIV-1 Vpu Mediates HLA-C Downregulation |
| Q45323939 | HIV-1 and Hepatitis C virus selection bottleneck in Chinese people who inject drugs |
| Q91887792 | HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naïve recently infected individuals |
| Q28606620 | HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders |
| Q35196509 | HIV-1 target cells in the CNS. |
| Q28536682 | HIV-1 transmission during early infection in men who have sex with men: a phylodynamic analysis |
| Q35749934 | HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression |
| Q36363966 | Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host |
| Q36827377 | Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock |
| Q35188022 | High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection |
| Q33748868 | High-accuracy identification of incident HIV-1 infections using a sequence clustering based diversity measure |
| Q34662575 | Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide |
| Q42633023 | Highlighting the crucial role of Hangzhou in HIV-1 transmission among men who have sex with men in Zhejiang, China |
| Q33630471 | Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers |
| Q27318508 | Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques |
| Q37182674 | Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection |
| Q36702615 | Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time |
| Q55299659 | Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes. |
| Q39615794 | Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques. |
| Q52590774 | Identification of Unequally Represented Founder Viruses Among Tissues in Very Early SIV Rectal Transmission. |
| Q36484034 | Identification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques |
| Q35172385 | Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4 |
| Q35798108 | Immune-mediated attenuation of HIV-1 |
| Q51002244 | Immunogenicity of sequences around HIV-1 protease cleavage sites: potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sites. |
| Q34460987 | Implications of HIV PrEP trials results |
| Q36978467 | Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy |
| Q38009870 | Improved outlook on HIV-1 prevention and vaccine development |
| Q52577900 | Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma. |
| Q36086631 | Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication |
| Q38674348 | Latino Sexual Beliefs Scale: An Exploratory Factor Analysis of Latino Men Who Have Sex With Men. |
| Q30490195 | Lessons from acute HIV infection |
| Q36299730 | Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis |
| Q61806694 | Link between the numbers of particles and variants founding new HIV-1 infections depends on the timing of transmission |
| Q34802271 | Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users |
| Q34120840 | Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys |
| Q35887051 | Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis |
| Q36083337 | Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials |
| Q35091012 | Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule |
| Q89830547 | Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials |
| Q35276750 | Mechanisms and factors that influence high frequency retroviral recombination |
| Q64235564 | Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis |
| Q30235142 | Molecular Epidemiology of Human Immunodeficiency Virus. |
| Q36532973 | Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones |
| Q37247492 | Molecular mechanisms of HIV type 1 prophylaxis failure revealed by single-genome sequencing |
| Q33945571 | Molecular tools for studying HIV transmission in sexual networks |
| Q33900353 | Molecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection events |
| Q35868061 | Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites |
| Q36559660 | Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus |
| Q56880081 | New insights into the evolutionary rate of HIV-1 at the within-host and epidemiological levels |
| Q35873113 | Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghana |
| Q38936872 | Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences |
| Q36154787 | Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N. |
| Q38204789 | Pathophysiological mechanisms of headache in patients with HIV. |
| Q42680526 | Patterns and rates of viral evolution in HIV-1 subtype B infected females and males |
| Q33888718 | Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention |
| Q35192915 | Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins |
| Q34336058 | Phenotypic properties of transmitted founder HIV-1 |
| Q30404569 | Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants |
| Q59355665 | Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants |
| Q36684805 | Phylogenetically resolving epidemiologic linkage. |
| Q36839567 | Pre-exposure prophylaxis for HIV prevention: how to predict success |
| Q28478459 | Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection |
| Q38631923 | Primary infection by a human immunodeficiency virus with atypical coreceptor tropism |
| Q37737052 | Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics |
| Q34117097 | Protection in macaques immunized with HIV-1 candidate vaccines can be predicted using the kinetics of their neutralizing antibodies |
| Q33770687 | Proteomic analysis of HIV-infected macrophages |
| Q37547061 | Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities |
| Q38849453 | Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection |
| Q34269570 | Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection. |
| Q34575590 | Rectal microbicide development. |
| Q34042642 | Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections |
| Q64251256 | Reduction of HIV-1 Reservoir Size and Diversity After 1 Year of cART Among Brazilian Individuals Starting Treatment During Early Stages of Acute Infection |
| Q34243486 | Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation. |
| Q37532983 | Relative resistance of HIV-1 founder viruses to control by interferon-alpha |
| Q37612507 | Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness |
| Q35581949 | SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma |
| Q37003000 | SPMM: estimating infection duration of multivariant HIV-1 infections |
| Q35943521 | Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site |
| Q35018140 | Selective transmission of R5 HIV-1 variants: where is the gatekeeper? |
| Q27331721 | Semen CD4+ T cells and macrophages are productively infected at all stages of SIV infection in macaques |
| Q34853144 | Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner |
| Q34285912 | Simple epidemiological dynamics explain phylogenetic clustering of HIV from patients with recent infection |
| Q36433960 | Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification |
| Q33921277 | Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages |
| Q30238730 | Survivors Remorse: antibody-mediated protection against HIV-1. |
| Q40091554 | The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards |
| Q36856091 | The HIV-1 env protein: a coat of many colors |
| Q42314454 | The HIV-1 transmission bottleneck |
| Q35599324 | The impact of within-herd genetic variation upon inferred transmission trees for foot-and-mouth disease virus |
| Q37481983 | The intra-host evolutionary and population dynamics of human immunodeficiency virus type 1: a phylogenetic perspective |
| Q37683788 | The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection |
| Q38021263 | The origin of genetic diversity in HIV-1. |
| Q37365618 | The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context? |
| Q37233074 | Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs |
| Q35914315 | Tracking the Emergence of Host-Specific Simian Immunodeficiency Virus env and nef Populations Reveals nef Early Adaptation and Convergent Evolution in Brain of Naturally Progressing Rhesus Macaques |
| Q27313356 | Tracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmission |
| Q37464540 | Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences |
| Q33680395 | Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing |
| Q33849796 | Transmission of single and multiple viral variants in primary HIV-1 subtype C infection |
| Q36607127 | Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. |
| Q36000722 | Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7 |
| Q89621084 | Triple HIV-1 Infection Is Associated With Faster CD4+ T-Cell Decline |
| Q92523996 | Uncovering Virus-Virus Interactions by Unifying Approaches and Harnessing High-Throughput Tools |
| Q37395749 | Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes |
| Q28743210 | Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection |
| Q26861425 | Using nonhuman primates to model HIV transmission |
| Q30411492 | Vaccine design for CD8 T lymphocyte responses |
| Q60908099 | Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers |
| Q34170655 | Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis |
| Q35593158 | Viral determinants of HIV-1 macrophage tropism |
| Q33877419 | Wide variation in the multiplicity of HIV-1 infection among injection drug users |
Search more.